US Patent Issued to Regeneron Pharmaceuticals on July 1 for "Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody" (New York, Connecticut, New Jersey Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,665, issued on July 1, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody" was invented by Aristides Economides (Tarrytown, N.Y.), Eduardo Forleo Neto (Greenwich, Conn.), Dinko Gonzalez Trotter (Baldwin Place, N.Y.), Gary Herman (Princeton, N.J.), Andrew Rankin (Stamford, Conn.) and Scott Mellis (New Rochelle, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating fibrodysplasia ossificans progressiva (FOP) in human subjects are provided. Such methods involve administering to a subject having FOP a therapeutically effec...